Cetuximab-based therapy versus non-cetuximab therapy for advanced cancer: a meta-analysis of 17 randomized controlled trials.
作者： Lidan Liu , Yunfei Cao , Aihua Tan , Cun Liao , Feng Gao
DOI: 10.1007/S00280-009-1090-X
关键词: Carcinoma 、 Treatment outcome 、 MEDLINE 、 Medicine 、 Advanced cancer 、 Randomized controlled trial 、 Meta-analysis 、 Internal medicine 、 Monoclonal 、 Oncology 、 Cetuximab
摘要: Purpose To assess the efficacy and safety of cetuximab-based therapy versus non-cetuximab for advanced cancer.
springer.com
sci-hub.se 参考文章(50)
Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer, Jantien Wanders, Richard S. Kaplan, Larry Rubinstein, Jaap Verweij, Martine Van Glabbeke, Allan T. van Oosterom, Michaele C. Christian, Steve G. Gwyther, New Guidelines to Evaluate the Response to Treatment in Solid Tumors JNCI: Journal of the National Cancer Institute. ,vol. 92, pp. 205- 216 ,(2000) , 10.1093/JNCI/92.3.205
David Cunningham, Yves Humblet, Salvatore Siena, David Khayat, Harry Bleiberg, Armando Santoro, Danny Bets, Matthias Mueser, Andreas Harstrick, Chris Verslype, Ian Chau, Eric Van Cutsem, None, Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. The New England Journal of Medicine. ,vol. 351, pp. 337- 345 ,(2004) , 10.1056/NEJMOA033025
Cornelis J.A. Punt, Miriam Koopman, Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer. Journal of Clinical Oncology. ,vol. 26, pp. 1907- 1909 ,(2008) , 10.1200/JCO.2007.15.9640
Carsten Bokemeyer, Igor Bondarenko, Anatoly Makhson, Joerg T. Hartmann, Jorge Aparicio, Filippo de Braud, Serban Donea, Heinz Ludwig, Gunter Schuch, Christopher Stroh, Anja H. Loos, Angela Zubel, Piotr Koralewski, Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer Journal of Clinical Oncology. ,vol. 27, pp. 663- 671 ,(2009) , 10.1200/JCO.2008.20.8397
James A. Bonner, Nita J. Maihle, Beth R. Folven, Teresa J.H. Christianson, Kristen spain, The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities International Journal of Radiation Oncology Biology Physics. ,vol. 29, pp. 243- 247 ,(1994) , 10.1016/0360-3016(94)90269-0
Christos S. Karapetis, Shirin Khambata-Ford, Derek J. Jonker, Chris J. O'Callaghan, Dongsheng Tu, Niall C. Tebbutt, R. John Simes, Haji Chalchal, Jeremy D. Shapiro, Sonia Robitaille, Timothy J. Price, Lois Shepherd, Heather-Jane Au, Christiane Langer, Malcolm J. Moore, John R. Zalcberg, K-ras mutations and benefit from cetuximab in advanced colorectal cancer. The New England Journal of Medicine. ,vol. 359, pp. 1757- 1765 ,(2008) , 10.1056/NEJMOA0804385
James A Bonner, Paul M Harari, Jordi Giralt, Nozar Azarnia, Dong M Shin, Roger B Cohen, Christopher U Jones, Ranjan Sur, David Raben, Jacek Jassem, Roger Ove, Merrill S Kies, Jose Baselga, Hagop Youssoufian, Nadia Amellal, Eric K Rowinsky, K Kian Ang, None, Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck The New England Journal of Medicine. ,vol. 354, pp. 567- 578 ,(2006) , 10.1056/NEJMOA053422
Alberto F. Sobrero, Joan Maurel, Louis Fehrenbacher, Werner Scheithauer, Yousif A. Abubakr, Manfred P. Lutz, M. Eugenia Vega-Villegas, Cathy Eng, Ernst U. Steinhauer, Jana Prausova, Heinz-Josef Lenz, Christophe Borg, Gary Middleton, Hendrik Kröning, Gabriele Luppi, Oliver Kisker, Angela Zubel, Christiane Langer, Justin Kopit, Howard A. Burris, EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer Journal of Clinical Oncology. ,vol. 26, pp. 2311- 2319 ,(2008) , 10.1200/JCO.2007.13.1193
David J. McConkey, Charles A. Portera, Douglas B. Evans, Daniel J. Hicklin, Matthew T. Harbison, Darren W. Davis, James L. Abbruzzese, Robert Radinsky, Rachel Tsan, Christiane J. Bruns, Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms. Clinical Cancer Research. ,vol. 6, pp. 1936- 1948 ,(2000)
Leonard B. Saltz, Neal J. Meropol, Patrick J. Loehrer, Michael N. Needle, Justin Kopit, Robert J. Mayer, Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor Journal of Clinical Oncology. ,vol. 22, pp. 1201- 1208 ,(2004) , 10.1200/JCO.2004.10.182